Cost-effectiveness of rosiglitazone for treatment of type 2 diabetes in Portugal using different methods to model clinical effects

Taylor , MJBagust , APereira, JoãoMendes da Costa, SBeale, SShearer, A2018-06-122018-06-122006-01-011098-3015PURE: 406062PURE UUID: 032dbf83-70e5-4e26-8344-95096b2a5cc2researchoutputwizard: 9534WOS: 000240922000149https://www.valueinhealthjournal.com/article/S1098-3015(10)63296-2/abstract?code=jval-site73895engSDG 3 - Good Health and Well-beingCost-effectiveness of rosiglitazone for treatment of type 2 diabetes in Portugal using different methods to model clinical effectsconference objecthttps://www.valueinhealthjournal.com/article/S1098-3015(10)63296-2/abstract?code=jval-site